CN1273142C - 阿齐霉素的乙醇化物,制备方法以及医药组合物 - Google Patents

阿齐霉素的乙醇化物,制备方法以及医药组合物 Download PDF

Info

Publication number
CN1273142C
CN1273142C CNB998158542A CN99815854A CN1273142C CN 1273142 C CN1273142 C CN 1273142C CN B998158542 A CNB998158542 A CN B998158542A CN 99815854 A CN99815854 A CN 99815854A CN 1273142 C CN1273142 C CN 1273142C
Authority
CN
China
Prior art keywords
azithromycin
ethanolate
water
weight
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998158542A
Other languages
English (en)
Chinese (zh)
Other versions
CN1334735A (zh
Inventor
C·辛格
J·阿伦希梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22332273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1273142(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of CN1334735A publication Critical patent/CN1334735A/zh
Application granted granted Critical
Publication of CN1273142C publication Critical patent/CN1273142C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNB998158542A 1998-11-30 1999-11-30 阿齐霉素的乙醇化物,制备方法以及医药组合物 Expired - Fee Related CN1273142C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11029898P 1998-11-30 1998-11-30
US60/110,298 1998-11-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100785525A Division CN100339384C (zh) 1998-11-30 1999-11-30 阿齐霉素的乙醇化物，制备方法以及医药组合物

Publications (2)

Publication Number Publication Date
CN1334735A CN1334735A (zh) 2002-02-06
CN1273142C true CN1273142C (zh) 2006-09-06

Family

ID=22332273

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB998158542A Expired - Fee Related CN1273142C (zh) 1998-11-30 1999-11-30 阿齐霉素的乙醇化物,制备方法以及医药组合物
CNB2005100785525A Expired - Fee Related CN100339384C (zh) 1998-11-30 1999-11-30 阿齐霉素的乙醇化物，制备方法以及医药组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNB2005100785525A Expired - Fee Related CN100339384C (zh) 1998-11-30 1999-11-30 阿齐霉素的乙醇化物，制备方法以及医药组合物

Country Status (26)

Country Link
US (1) US6365574B2 (enExample)
EP (2) EP1152765B1 (enExample)
JP (1) JP2002531409A (enExample)
KR (1) KR100603226B1 (enExample)
CN (2) CN1273142C (enExample)
AP (1) AP1709A (enExample)
AT (1) ATE279200T1 (enExample)
AU (1) AU768219B2 (enExample)
BG (1) BG105547A (enExample)
CA (1) CA2352562A1 (enExample)
CZ (1) CZ20011886A3 (enExample)
DE (1) DE69921192T2 (enExample)
DK (1) DK1152765T3 (enExample)
ES (1) ES2229804T3 (enExample)
HK (1) HK1043725B (enExample)
HU (1) HUP0104241A3 (enExample)
IL (1) IL143376A0 (enExample)
LV (1) LV12735B (enExample)
NZ (1) NZ512496A (enExample)
PL (1) PL197894B1 (enExample)
PT (1) PT1152765E (enExample)
RO (1) RO121408B1 (enExample)
RU (1) RU2240124C2 (enExample)
SI (1) SI20639A (enExample)
WO (1) WO2000032203A1 (enExample)
ZA (1) ZA200104312B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
EP1152765B1 (en) * 1998-11-30 2004-10-13 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
UA76967C2 (uk) * 2000-11-27 2006-10-16 Сандоз Аг Азитроміцин у формі моногідрату, фармацевтична композиція та спосіб його одержання
PL207076B1 (pl) * 2000-11-27 2010-10-29 Sandoz Ag Sposób wytwarzania jednowodzianu azytromycyny
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
EP1390377B1 (en) 2001-05-22 2006-03-08 Pfizer Products Inc. New crystal form of azithromycin
EP1671979B1 (en) * 2001-05-22 2008-08-13 Pfizer Products Inc. New Cristal Form of Azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1541134A3 (en) * 2001-10-18 2007-06-06 Teva Pharmaceutical Industries Limited Stabilized azithromycin compositions
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
DK1446010T3 (da) 2001-10-18 2009-06-22 Teva Pharma Stabiliseret azithromycin-sammensætning
NZ532063A (en) * 2001-12-21 2006-03-31 Pfizer Prod Inc Methods for wet granulating azithromycin
JP2005513099A (ja) * 2001-12-21 2005-05-12 ファイザー・プロダクツ・インク アジスロマイシンの直接的に圧縮可能な配合品
NZ534234A (en) * 2002-02-01 2007-05-31 Pfizer Prod Inc Dry granulated formulations of non-dihydrate form of azithromycin
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
EP1694304A2 (en) * 2003-12-04 2006-08-30 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
BRPI0416534A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
RU2331410C2 (ru) * 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2549225A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
CA2591744A1 (en) * 2004-12-21 2006-06-29 Pfizer Products Inc. Stable non-dihydrate azithromycin oral suspensions
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
US9433516B2 (en) * 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
MX2011009548A (es) 2009-03-13 2011-12-14 Da Volterra Composiciones y metodos para la eliminacion de bacterias gram-negativas.
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN103983730B (zh) * 2014-06-11 2015-09-30 北京市药品检验所 阿奇霉素或其制剂中的杂质检查方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
CN1093370A (zh) * 1993-12-10 1994-10-12 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
CN1161971A (zh) * 1997-01-03 1997-10-15 石家庄制药集团有限公司 一种阿齐霉素结晶及其制备方法
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
EP1152765B1 (en) * 1998-11-30 2004-10-13 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
EP1390377B1 (en) * 2001-05-22 2006-03-08 Pfizer Products Inc. New crystal form of azithromycin

Also Published As

Publication number Publication date
HK1043725B (en) 2005-05-06
AU768219B2 (en) 2003-12-04
AU3106500A (en) 2000-06-19
ZA200104312B (en) 2001-11-28
CN1737008A (zh) 2006-02-22
DE69921192D1 (de) 2004-11-18
BG105547A (en) 2001-12-31
US6365574B2 (en) 2002-04-02
CN100339384C (zh) 2007-09-26
PL197894B1 (pl) 2008-05-30
CZ20011886A3 (cs) 2001-10-17
EP1152765A1 (en) 2001-11-14
AP2001002183A0 (en) 2001-06-30
HK1043725A1 (en) 2002-09-27
SI20639A (sl) 2002-02-28
HUP0104241A3 (en) 2003-12-29
ES2229804T3 (es) 2005-04-16
PT1152765E (pt) 2004-12-31
KR100603226B1 (ko) 2006-08-28
LV12735B (en) 2002-03-20
HUP0104241A2 (hu) 2002-03-28
EP1484062A1 (en) 2004-12-08
EP1152765A4 (en) 2002-07-17
RO121408B1 (ro) 2007-05-30
RU2240124C2 (ru) 2004-11-20
US20020007049A1 (en) 2002-01-17
CA2352562A1 (en) 2000-06-08
ATE279200T1 (de) 2004-10-15
AP1709A (en) 2007-02-27
EP1152765B1 (en) 2004-10-13
KR20010099806A (ko) 2001-11-09
PL347971A1 (en) 2002-05-06
DE69921192T2 (de) 2006-02-16
DK1152765T3 (da) 2005-01-31
CN1334735A (zh) 2002-02-06
IL143376A0 (en) 2002-04-21
JP2002531409A (ja) 2002-09-24
LV12735A (en) 2001-10-20
NZ512496A (en) 2003-02-28
WO2000032203A1 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
CN1273142C (zh) 阿齐霉素的乙醇化物,制备方法以及医药组合物
WO2000032203A9 (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6586576B2 (en) Preparation method of azithromycin hydrates
US7205394B2 (en) Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same
IL101705A (en) Acetone, 1-butanol 1-propanol and 2-propanol solvates of dirithromycin and process for their preparation
EP1189913B1 (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
CN1309413C (zh) 四肽衍生物的晶体
WO2018067805A1 (en) Solid state forms of sotagliflozin
KR100509737B1 (ko) 7-아미노세팔로스포란산의 결정화 방법
CN120829374A (zh) 拉法姆林的新晶型及其制备方法与用途
CN119219663A (zh) 头孢匹胺钠的晶型、包含其的头孢匹胺钠及其制备方法
HK1047112A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
HK1118294A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee